Fabry Disease Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Fabry Disease market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 1.3% during the forecast period.
This report presents the market size and development trends by detailing the Fabry Disease market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Fabry Disease market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Fabry Disease industry and will help you to build a panoramic view of the industrial development.
Fabry Disease Market, By Type:
Kidney
Heart
Skin
Fabry Disease Market, By Application:
Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Substrate Reduction Therapy (SRT)
Others
Some of the leading players are as follows:
Idorsia Pharmaceuticals Ltd.
Shire Plc.
Greenovation Biotech GmbH
Avrobio Inc.
Protalix Biotherapeutics Inc.
Green Cross Pharma Pte Ltd.
JCR Pharmaceuticals Co Ltd.
Moderna Therapeutics Inc.
Amicus Therapeutics Inc.
Sanofi S.A.
ISU Abxis Co Ltd.
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Fabry Disease Market: Technology Type Analysis
-
4.1 Fabry Disease Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Fabry Disease Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Kidney
4.3.2 Heart
4.3.3 Skin
5 Fabry Disease Market: Product Analysis
-
5.1 Fabry Disease Product Market Share Analysis, 2018 & 2026
-
5.2 Fabry Disease Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Fabry Disease Market: Application Analysis
-
6.1 Fabry Disease Application Market Share Analysis, 2018 & 2026
-
6.2 Fabry Disease Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Enzyme Replacement Therapy (ERT)
6.3.2 Chaperone Treatment
6.3.3 Substrate Reduction Therapy (SRT)
6.3.4 Others
7 Fabry Disease Market: Regional Analysis
-
7.1 Fabry Disease Regional Market Share Analysis, 2018 & 2026
-
7.2 Fabry Disease Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Idorsia Pharmaceuticals Ltd.
9.1.1 Idorsia Pharmaceuticals Ltd. Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Shire Plc.
9.2.1 Shire Plc. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Greenovation Biotech GmbH
9.3.1 Greenovation Biotech GmbH Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Avrobio Inc.
9.4.1 Avrobio Inc. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Protalix Biotherapeutics Inc.
9.5.1 Protalix Biotherapeutics Inc. Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Green Cross Pharma Pte Ltd.
9.6.1 Green Cross Pharma Pte Ltd. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 JCR Pharmaceuticals Co Ltd.
9.7.1 JCR Pharmaceuticals Co Ltd. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Moderna Therapeutics Inc.
9.8.1 Moderna Therapeutics Inc. Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Amicus Therapeutics Inc.
9.9.1 Amicus Therapeutics Inc. Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Sanofi S.A.
9.10.1 Sanofi S.A. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 ISU Abxis Co Ltd.
9.11.1 ISU Abxis Co Ltd. Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 86 Figures and 156 Tables)
Figure Kidney Fabry Disease market, 2015 - 2026 (USD Million)
Figure Heart Fabry Disease market, 2015 - 2026 (USD Million)
Figure Skin Fabry Disease market, 2015 - 2026 (USD Million)
Figure Enzyme Replacement Therapy (ERT) market, 2015 - 2026 (USD Million)
Figure Chaperone Treatment market, 2015 - 2026 (USD Million)
Figure Substrate Reduction Therapy (SRT) market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Fabry Disease market, by country, 2015 - 2026 (USD Million)
-
Table North America Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table North America Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table North America Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Canada Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Canada Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Europe Fabry Disease market, by country, 2015 - 2026 (USD Million)
-
Table Europe Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Europe Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Europe Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Germany Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Germany Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table France Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table France Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Italy Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Italy Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Spain Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Spain Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Fabry Disease market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table China Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table China Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Japan Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Japan Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table India Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table India Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Fabry Disease market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table MEA Fabry Disease market, by country, 2015 - 2026 (USD Million)
-
Table MEA Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table MEA Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table MEA Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Fabry Disease market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Fabry Disease market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Fabry Disease market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Idorsia Pharmaceuticals Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shire Plc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Greenovation Biotech GmbH Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Avrobio Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Protalix Biotherapeutics Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Green Cross Pharma Pte Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table JCR Pharmaceuticals Co Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Moderna Therapeutics Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amicus Therapeutics Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi S.A. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ISU Abxis Co Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Report Purchase
